Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1.

Guo H, Treude F, Krämer OH, Lüscher B, Hartkamp J.

Sci Rep. 2019 Jun 19;9(1):8755. doi: 10.1038/s41598-019-45209-9.

2.

Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells.

Pons M, Reichardt CM, Hennig D, Nathan A, Kiweler N, Stocking C, Wichmann C, Christmann M, Butter F, Reichardt S, Schneider G, Heinzel T, Englert C, Hartkamp J, Krämer OH, Mahendrarajah N.

Arch Toxicol. 2018 Jun;92(6):2119-2135. doi: 10.1007/s00204-018-2202-3. Epub 2018 Mar 27.

PMID:
29589053
3.

Sulfoximines as ATR inhibitors: Analogs of VE-821.

Hendriks CMM, Hartkamp J, Wiezorek S, Steinkamp AD, Rossetti G, Lüscher B, Bolm C.

Bioorg Med Chem Lett. 2017 Jun 15;27(12):2659-2662. doi: 10.1016/j.bmcl.2017.04.026. Epub 2017 Apr 8.

PMID:
28479198
4.

Assessment of HDACi-Induced Protein Cleavage by Caspases.

Treude F, Gladbach T, Plaster J, Hartkamp J.

Methods Mol Biol. 2017;1510:11-22.

PMID:
27761810
5.

Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis.

Treude F, Kappes F, Fahrenkamp D, Müller-Newen G, Dajas-Bailador F, Krämer OH, Lüscher B, Hartkamp J.

Oncotarget. 2014 May 30;5(10):2988-98.

6.

Caspase-dependent cleavage of the mono-ADP-ribosyltransferase ARTD10 interferes with its pro-apoptotic function.

Herzog N, Hartkamp JD, Verheugd P, Treude F, Forst AH, Feijs KL, Lippok BE, Kremmer E, Kleine H, Lüscher B.

FEBS J. 2013 Mar;280(5):1330-43. doi: 10.1111/febs.12124. Epub 2013 Feb 13.

7.

SIAH proteins: critical roles in leukemogenesis.

Krämer OH, Stauber RH, Bug G, Hartkamp J, Knauer SK.

Leukemia. 2013 Apr;27(4):792-802. doi: 10.1038/leu.2012.284. Epub 2012 Oct 5. Review.

PMID:
23038274
8.

HtrA2, taming the oncogenic activities of WT1.

Hartkamp J, Roberts SG.

Cell Cycle. 2010 Jul 1;9(13):2508-14.

9.

The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi.

Hartkamp J, Carpenter B, Roberts SG.

Mol Cell. 2010 Jan 29;37(2):159-71. doi: 10.1016/j.molcel.2009.12.023.

10.

The role of the Wilms' tumour-suppressor protein WT1 in apoptosis.

Hartkamp J, Roberts SG.

Biochem Soc Trans. 2008 Aug;36(Pt 4):629-31. doi: 10.1042/BST0360629. Review.

PMID:
18631130
11.

Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.

Jaeschke A, Hartkamp J, Saitoh M, Roworth W, Nobukuni T, Hodges A, Sampson J, Thomas G, Lamb R.

J Cell Biol. 2002 Oct 28;159(2):217-24. Epub 2002 Oct 28.

12.

Truncation of the neuritogenic peptide bP2(60-70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation.

Offenhäusser M, Herr AS, Hartkamp J, Wauben M, Magnus T, Grauer O, Seubert S, Weishaupt A, Toyka KV, Gold R, Troppmair J.

J Neuroimmunol. 2002 Aug;129(1-2):97-105.

PMID:
12161025
13.
14.
15.

[Study of the assay of pituitary adrenocorticotropic preparations (ACTH) with prolonged action].

CHEYMOL J, HARTKAMP J, HENRY R, OGER J.

Therapie. 1960;15:1129-37. French. No abstract available.

PMID:
13692985

Supplemental Content

Loading ...
Support Center